Evaluating the association between walking speed and reduced cardio-cerebrovascular events in hemodialysis patients: A 7-year cohort study

被引:0
|
作者
Abe Y. [1 ]
Matsunaga A. [1 ]
Matsuzawa R. [2 ]
Yoneki K. [1 ,3 ]
Harada M. [1 ]
Watanabe T. [1 ]
Kutsuna T. [4 ]
Kimura M. [5 ]
Shigeta K. [1 ]
Takeuchi Y. [6 ]
Yoshida A. [3 ]
机构
[1] Department of Rehabilitation Sciences, Kitasato University, Graduate School of Medical Sciences, 1-15-1 Kitasato, Sagamihara, Kanagawa
[2] Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Kanagawa
[3] Sagami Junkanki Clinic, Sagamihara, Kanagawa
[4] Department of Rehabilitation, Kitasato University East Hospital, Sagamihara, Kanagawa
[5] School of Allied Health Sciences, Kitasato University, Sagamihara, Kanagawa
[6] School of Medicine, Kitasato University, Sagamihara, Kanagawa
基金
日本学术振兴会;
关键词
Cardio-cerebrovascular event; Disease management; Hemodialysis patient; Walking ability; Walking speed;
D O I
10.1186/s41100-016-0063-x
中图分类号
学科分类号
摘要
Background: Deterioration in walking ability characterized by slow walking speed is associated with an increased risk of mortality in patients on hemodialysis (HD), but few studies have examined the potential for walking speed to reduce the incidence of clinical events. In this study, we assessed a range of maximum walking speeds (MWS) with regard to their capacity to reduce cardio-cerebrovascular events in HD patients. Methods: In total, 188 Japanese outpatients (90 men, 98 women; mean age, 65 years) undergoing maintenance HD three times a week were monitored for 7 years. We measured clinical characteristics and MWS at baseline and followed these patients to track any cardio-cerebrovascular events. Patients were divided into quartiles (Q1 = lowest, Q4 = highest) based on MWS for each sex. Cox proportional hazards regression and Kaplan-Meier estimates were used to assess the contribution of MWS to cardio-cerebrovascular events. Results: During the follow-up period, cardio-cerebrovascular events occurred in 42 patients. After adjusting for potential confounders, the hazard ratio for events per 10 m/min increase in MWS was 0.77 (95 % confidence interval: 0.65-0.92; P = 0.004). Seven-year cumulative incidence rates were 36, 32, 13, and 9 % for Q1 through Q4, respectively, and a significant difference across MWS quartiles was observed (P < 0.001). While the incidence rates did not significantly differ between Q1 and Q2 or between Q3 and Q4, Kaplan-Meier curves clearly differed between Q2 and Q3. Conclusions: Our findings suggest that more than the MWS level of Q3 (≥89 m/min in men and ≥85 m/min in women) may serve as important MWS values for disease management in ambulatory HD patients. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] Dynapenia is an independent predictor of cardio-cerebrovascular events in patients undergoing hemodialysis
    Hayashi, Hiroya
    Izumiya, Yasuhiro
    Hayashi, Ou
    Ichii, Mitsuru
    Tsujimoto, Yoshihiro
    Yoshiyama, Minoru
    [J]. HEART AND VESSELS, 2022, 37 (06) : 1066 - 1074
  • [2] Dynapenia is an independent predictor of cardio-cerebrovascular events in patients undergoing hemodialysis
    Hiroya Hayashi
    Yasuhiro Izumiya
    Ou Hayashi
    Mitsuru Ichii
    Yoshihiro Tsujimoto
    Minoru Yoshiyama
    [J]. Heart and Vessels, 2022, 37 : 1066 - 1074
  • [3] EFFECTS OF PHYSICAL INACTIVITY ON RISK OF HOSPITALIZATION FOR CARDIO-CEREBROVASCULAR EVENTS IN HEMODIALYSIS PATIENTS
    Matsuzawa, Ryota
    Matsunaga, Atsuhiko
    Ishii, Akira
    Abe, Yoshifumi
    Yoneki, Kei
    Harada, Manae
    Takagi, Yutaka
    Yoshida, Atsushi
    Takahira, Naonobu
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 449 - 449
  • [4] Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study
    Hong, Kwan
    Kisiju, Trishna
    Kim, Jeehyun
    Chun, Byung Chul
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [5] Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium
    Li, Penglei
    Lv, Tiegang
    Xu, Liping
    Yu, Wenlu
    Lu, Yuanyuan
    Li, Yuanyuan
    Hao, Jian
    [J]. RENAL FAILURE, 2024, 46 (01)
  • [6] Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study
    Steenhuis, Dennis
    de Vos, Stijn
    Bos, Jens H. J.
    Hak, Eelko
    [J]. PREVENTIVE MEDICINE REPORTS, 2023, 34
  • [7] The Impact of Sedation on Cardio-Cerebrovascular Adverse Events after Surveillance Esophagogastroduodenoscopy in Patients with Gastric Cancer: A Nationwide Population-Based Cohort Study
    Kim, Sang Yoon
    Lee, Jun Kyu
    Lee, Kwang Hyuck
    Jang, Jae-Young
    Kim, Byung-Wook
    KSGE
    [J]. GUT AND LIVER, 2024, 18 (02)
  • [8] The Association between Social Support, Metabolic Syndrome, and Incidence of Cardio-Cerebrovascular Diseases in Older Adults: The ARIRANG Study
    Nam, Hae-Kweun
    Chang, Sei-Jin
    Kim, Chun-Bae
    Jeong, Kyoung Sook
    Kim, Sung-Kyung
    Kang, Dae Ryong
    Jeong, Yong Whi
    Lee, Hocheol
    Zhao, Bo
    Koh, Sang-Baek
    [J]. YONSEI MEDICAL JOURNAL, 2024, 65 (06) : 363 - 370
  • [9] Association between urinary IPM3 and the presence of cardio-cerebrovascular diseases: a cross-sectional study
    Qi Tian
    Danqing Huang
    [J]. Environmental Science and Pollution Research, 2023, 30 : 75817 - 75822
  • [10] Association between urinary IPM3 and the presence of cardio-cerebrovascular diseases: a cross-sectional study
    Tian, Qi
    Huang, Danqing
    [J]. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2023, 30 (30) : 75817 - 75822